Loading
Life sciences · Journal article
International Journal of Pharmacy and Pharmaceutical Sciences · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Objective: To formulate and evaluate palbociclib-loaded nanosponges (PB-NSPs) as a controlled drug delivery system to improve the solubility, stability, and release behavior of palbociclib for cancer therapy. Methods: PB-NSPs were prepared using β-cyclodextrin (β-CD) and characterized for particle size, zeta potential, encapsulation efficiency, and morphology. Cytotoxicity was evaluated by MTT assay against MCF-7 and A498 cell lines. In vitro drug release studies were performed to assess the release characteristics of the formulation. Results: The optimized PB-NSPs exhibited a particle size of 149.7±2.6 nm, zeta potential of −23.6±2.16 mV, and encapsulation efficiency of 77.33±2.82%. Cytotoxicity studies demonstrated concentration-dependent reduction in cell viability. Pure palbociclib showed IC₅₀ values of 43.168 µg/ml in MCF-7 cells and 58.11 µg/ml in A498 cells, whereas PB-NSPs showed IC₅₀ values of 54.054 µg/ml and 63.77 µg/ml, respectively. Although PB-NSPs exhibited slightly higher IC₅₀ values than the pure drug in the 48 h assay, the formulation demonstrated sustained drug release and favorable physicochemical properties. Conclusion: PB-NSPs demonstrated desirable physicochemical characteristics and controlled release behavior, indicating their potential as a promising nanosponge-based drug delivery system for prolonged and targeted delivery of palbociclib in cancer therapy.